New Key Statistics Module, Z-Score and F-Score
NAS:RPRX Key Ratios
Market Cap $ M | 12,507.36 |
Enterprise Value $ M | 17,458.03 |
P/E(ttm) | 11.11 |
PE Ratio without NRI | 14.04 |
Forward PE Ratio | 8.24 |
Price/Book | 1.92 |
Price/Sales | 7.17 |
Price/Free Cash Flow | 5.66 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.40 |
Revenue (TTM) $ M | 2,354.00 |
EPS (TTM) $ | 2.52 |
Beneish M-Score | -3.03 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -23.00 |
y-y EBITDA Growth Rate % | 223.70 |
EV-to-EBIT | 9.25 |
EV-to-EBITDA | 9.25 |
PEG | -- |
Shares Outstanding M | 446.69 |
Net Margin (%) | 48.20 |
Operating Margin % | 63.37 |
Pre-tax Margin (%) | 72.20 |
Quick Ratio | 7.90 |
Current Ratio | 7.90 |
ROA % (ttm) | 6.82 |
ROE % (ttm) | 18.59 |
ROIC % (ttm) | 9.93 |
Dividend Yield % | 2.89 |
Altman Z-Score | 2.02 |
RPRX Number of Guru Trades
RPRX Volume of Guru Trades
Gurus Latest Trades with NAS:RPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RPRX is held by these investors
Total 1
Royalty Pharma PLC Insider Transactions
No Available Data
News about NAS:RPRX
Total 0- 1